Vibrato Medical Closes $4M Series A Funding Round and Receives $1.5M NIH Grant
- Vibrato Medical
MONTIRVINE, Calif.–(BUSINESS WIRE)–Vibrato Medical, an innovator in the treatment of peripheral arterial disease (PAD), announced today that it has closed a $4M Series A funding round led by the Horowitz Group, a multi-asset class family investment office based in Newport Beach, CA, and has also received a $1.5M National Institutes of Health (NIH) grant. Together, funding will support the clinical trial of the company’s novel, noninvasive, wearable device designed to treat patients with critical limb ischemia (CLI), an advanced stage of PAD, from the convenience of their home. Read more…
Related Reading
News / Regulatory Affairs / Small Business
Carbon Medical Technologies’ InjecSURE® Injection System Receives FDA 510(k) Clearance, Expanding CMT’s Portfolio of Urology Delivery Solutions
April 16, 2026
Saint Paul, MN – April 15, 2026. Carbon Medical Technologies, Inc. (CMT), a manufacturer of implantable medical devices and delivery systems utilizing proprietary technologies, is pleased to announce that its InjecSURE® Injection System has received clearance from the U.S. Food and Drug Administration (FDA) through the 510(k) pathway. This milestone marks the introduction of a new accessory system designed to support the delivery of syringe-based injectable materials into urethral tissues during cystoscopic procedures.
Blog / Business Development / Health Access / Small Business
Pro-Innovation Tax Policy Strengthens U.S. Medtech Leadership, Delivers for Patients
April 15, 2026
The tax incentives in the One Big Beautiful Bill Act passed by Congress and signed into law by President Trump last year are a prime example of the public policies reinforcing the U.S. position as the global leader in medtech innovation.
Resource / Regulatory Affairs
AdvaMed® Comment Letter to FDA: Exemptions from Premarket Notification Requirements for Class II Devices
April 15, 2026
AdvaMed’s® comments on FDA’s 510(k) exemption framework for Class II devices and its impact on innovation and patient access.
News / Business Development / Government & Legislative Affairs / Small Business
AdvaMed Thanks President Trump, Congress for Legislation Restoring Programs That Jumpstart Early-stage Medtech Innovation
April 14, 2026
WASHINGTON—AdvaMed, the Medtech Association, the largest trade association representing medtech innovators, thanked President Trump and Congress for enacting the Small Business Innovation and Economic Security Act (S. 3971). Signed into law, the legislation reauthorizes the federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.
Event / Regulatory Affairs
Pulse on MedTech: How the Industry is Reigniting Growth and Expanding Markets
April 30, 2026
11:00 AM – 12:00 PM
Join Ernst & Young LLP in this session that explores key trends shaping the sector.
Event / Regulatory Affairs
The UPC – Three Years In Cross-Border Medtech Patent Strategy in the New European Landscape
April 28, 2026
1:00 PM – 2:00 PM
Join McDermott Will & Schulte Law in this session that will explore practical, cross-border patent litigation strategies for navigating the UPC system specifically for the medtech sector.
Event / Regulatory Affairs
The State of the MedTech Customer Base
May 7, 2026
1:00 PM – 2:00 PM
Join L.E.K. Consulting to explore hospital financial health, purchasing behavior, and strategic priorities, and what they mean for medtech growth, partnerships, and innovation.
Event / Regulatory Affairs
Beyond the Silo: Why Fragmentation Is MedTech’s Biggest Threat
May 6, 2026
12:00 PM – 1:00 PM
Discover how Salesforce is helping medtech organizations improve margins and scale with AI powered, connected enterprise platforms.